VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 1525021
Sex: F
Age:
State: VA

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: High fever; Swollen lymph node; This is a spontaneous report from a contactable nurse, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 14:30 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus, legs restless, anxiety, depression, hypertension and COVID-19. Concomitant medications included metformin hydrochloride, sitagliptin phosphate monohydrate (JANUMET), semaglutide (OZEMPIC), propranolol (MANUFACTURER UNKNOWN), pramipexole dihydrochloride monohydrate (MIRAPEX) and citalopram (MANUFACTURER UNKNOWN) all are for an unknown indication and started from an unspecified date. The patient did not have a history of allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 19:00, the patient experienced high fever and swollen lymph node. Therapeutic measures were not taken as a result of the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events high fever and swollen lymph node was recovering, at the time of reporting. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: JANUMET; OZEMPIC; PROPRANOLOL; MIRAPEX; CITALOPRAM

Current Illness:

ID: 1525022
Sex: F
Age:
State: CA

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I woke up with fever; Severe headache; Eye and neck pain; Eye and neck pain; Body aches; Nausea; Vomited; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the arm right on 06Apr2021 at 14:30(at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer, clotting disorder, MTHFR gene mutation, shellfish allergy and MSG allergy. Concomitant medications included apixaban (ELIQUIS) and levothyroxine sodium (SYNTHROID 112); for unknown indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the arm right on 04Mar2021 at 15:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 05:00, in the morning the patient woke up with fever, severe headache, eye pain, neck pain, body aches, and then nausea. The patient vomited throughout the day violently and took promethazine for the nausea and immediately vomited that up. Before deciding to go the hospital, the patient tried promethazine suppository for nausea and 1 vicodin (these medications prescribed for a surgical procedure) and took them 3 times during the day as vomiting recurred after drug wore off. The medications offered some relief. On 08Apr2021, the patient had low grade headache and body aches and light nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with promethazine (MANUFACTURER UNKNOWN) and acetaminophen-hydrocodone (VICODIN). The clinical outcome of the events fever, severe headache, eye pain, neck pain, body aches, nausea and vomited were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ELIQUIS; SYNTHROID

Current Illness:

ID: 1525023
Sex: M
Age:
State: NV

Vax Date: 02/26/2021
Onset Date: 03/15/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Developed Ringing in left ear.; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 26Feb2021 at 12:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies to medications, food, or other products. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Mar2021, the patient developed ringing in left ear. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the event. The clinical outcome of the event developed ringing in left ear was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1525024
Sex: F
Age:
State: IN

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Extreme chills; Tiredness; Slight headache; Slight rash; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 24Mar2021 at 10:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, high cholesterol and pacemaker. The patient had no known allergies to food, medications, or other products. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), losartan potassium (LOSARTIN) and metoprolol (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 06:00, the patient experienced extreme chills, tiredness, slight headache and slight rash. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. On 08Apr2021, the patient underwent lab test which included nasal swab test and tested negative. The clinical outcome of the events extreme chills, tiredness, slight headache and slight rash was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ATORVASTATIN; LOSARTIN; METOPROLOL

Current Illness:

ID: 1525025
Sex: F
Age:
State: NM

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Throat seemed tight andhaving problems swallowing; Throat seemed tight andhaving problems swallowing; Burning in lungs; The swelling seemed to have subsided 30minutes later.; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 08Apr2021 at 10:15 (at the age of 55-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. Concomitant medications included levothyroxine sodium (THYROXINE) and levothyroxine (MANUFACTURER UNKNOWN); both from an unknown date for unknown indication. The patient previously received sulphur on unknown date for an unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 11:30, the patient experienced throat seemed tight and having problem swallowing, swelling, slight burning in lungs. The patient was traveling so got out of car and drank some water. The swelling seemed to have subsided 30 minutes later. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events throat seemed tight and having problem swallowing, swelling, slight burning in lungs were recovered on 08Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: THYROXINE; LEVOTHYROXINE

Current Illness:

ID: 1525026
Sex: M
Age:
State: CO

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 101.5 fever; Chills; Body aches; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 06Apr2021 at 09:30 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high and obesity and COVID-19 (Prior to the vaccination, the patient was diagnosed with COVID-19). The patient had no known allergies to medications, food or other products. The patient did not take any concomitant medications. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 06Apr2021 at 23:00, the patient experienced 101.5 fever, chills, body aches, headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of fever, chills, body aches, headache were resolved on an unknown date in Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1525027
Sex: F
Age:
State: PA

Vax Date: 04/05/2021
Onset Date: 04/06/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; severe body aches; chills; fatigue; arm pain; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 05Apr2021 at 09:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no allergies to medications, food, or other products. Concomitant medications included ethinylestradiol, ferrous fumarate, norethisterone acetate (LOESTRIN FE), cetirizine hydrochloride (ZYRTEC) and ibuprofen (ADVIL), all taken for unknown indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 15Mar2021 at 09:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 01:00, 18 hours after the vaccination, the patient experienced fever, severe body aches, chills, fatigue and pain in arm. Fever and chills subsided after several hours. Fatigue and arm pain continued for about 48 hours after the vaccine was administered. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events fever and chills were resolved on an unknown date in Apr2021, while that of severe body aches, fatigue and pain in arm were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LOESTRIN FE; Zyrtec; Advil

Current Illness:

ID: 1525028
Sex: F
Age:
State: OR

Vax Date: 04/02/2021
Onset Date: 04/03/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm underneath painful; Arm underneath swollen; Lymph nodes painful; Lymph nodes swollen; Left arm sore at injection site; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 02Apr2021 at 10:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis. The patient was allergic to sulfa (sulfonamide) and all GERD medications (drug allergy). Concomitant medications included ondansetron (ZOFRAN), vitamin d nos (MANUFACTURER UNKNOWN) and multi vitamin (MANUFACTURER UNKNOWN) all from an unknown date for an unknown indication and unknown if ongoing. The patient previously took polysorbate 80 (MANUFACTURER UNKNOWN), sodium sulfate (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously took SIMPONI ARIA IV (intravenous) 50mg for psoriatic arthritis. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Apr2021 at 16:00, the patient experienced left arm sore at injection site. On 04Apr2021 (24 hours later), the patient's arm underneath and lymph nodes were painful and swollen for 4 days. The events did not result in a visit to doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of these events. The clinical outcome of the event left arm sore at injection site was resolved on an unspecified date in 2021 while that of the events arm underneath painful, arm underneath swollen, lymph nodes painful and lymph nodes swollen were resolved on an unspecified date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: Zofran; VITAMIN D NOS

Current Illness:

ID: 1525029
Sex: F
Age:
State: WA

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vomiting; diarrhea; migraine; scalp sensitivity; chest pain; fatigue; body ache; fever; chills; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the arm left on 06Apr2021 at 15:30 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included salbutamol (ALBUTEROL), budesonide, formoterol fumarate (SYMBICORT). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 16Mar2021 at 16:15 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. The patient previously received amoxycillin (MANUFACTURER UNKNOWN) for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 07:00, the patient experienced vomiting, diarrhoea, migraine, scalp sensitivity, chest pain, fatigue, body ache, fever and chills. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcomes of the events vomiting, diarrhoea, migraine, scalp sensitivity, chest pain, fatigue, body ache, fever and chills were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Albuterol; SYMBICORT

Current Illness:

ID: 1525030
Sex: F
Age:
State: WI

Vax Date: 03/25/2021
Onset Date: 03/26/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: developed a scar - like one would if they were cut, that ended up being 3/4" long x 1/8 wide.; puckered /pulled skin; "slightly discolored from skin around it just likeany other scar would be"; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the arm left on 25Mar2021 at 10:30 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol, hypothyroid, anxiety, depression and was allergic to iodinated contrast agent (injectable contrast dye). The patient received unspecified medications within two weeks of vaccination and it was reported as "they don't all fit". The patient previously received venlafaxine (MANUFACTURER UNKNOWN) for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021 at 21:00, at the injection site, within about 36hrs, the patient had developed a scar - like one would if they were cut, that ended up being 3/4" long x 1/8" wide. It was "puckered" (pulled skin) and slightly discoloured from skin around it just like any other scar would be. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events injection site scar, "puckered" (pulled skin) and slightly discoloured from skin around it was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1525031
Sex: F
Age:
State: IL

Vax Date: 04/07/2021
Onset Date: 04/08/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen lymph nodes in both elbows; Numbness in right arm; Pain in right arm; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the arm left on 07Apr2021 at 13:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies. Concomitant medications included marajuana (MANAFACTURER UNKNOWN) daily, ibuprofen (MANUFACTURER UNKNOWN) occasionally for an unspecified indication. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on an unspecified date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 19:00 the patient experienced swollen lymph nodes in both elbows, the right lymph node was about the size of a quarter and was causing numbness and pain throughout the arm. The left was smaller, more like a small grape. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events swollen lymph node, pain in arm, numbness in arm was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: IBUPROFEN

Current Illness:

ID: 1525032
Sex: M
Age:
State: MD

Vax Date: 04/07/2021
Onset Date: 04/08/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 07Apr2021 at 15:45 (at the age of 17-year-old) as a single dose for COVID-19 immunisation. Medical history included Crohn's. The patient did not have any allergies to medications, food, or other products. Concomitant medications included infliximab (REMICADE) and levocetirizine dihydrochloride (XYZAL) both for unknown indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 17Mar2021 at 15:30 (at the age of 17-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 03:00, the patient experienced fever and chills. No therapeutic measures were taken as a result of the events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever and chills were not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: REMICADE; XYZAL

Current Illness:

ID: 1525033
Sex: F
Age:
State:

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Extreme fatigue; Sore arm at injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 07Apr2021 at 09:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient experienced extreme fatigue and sore arm at injection site ( vaccination site pain). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of extreme fatigue and sore arm at injection site were unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1525034
Sex: F
Age:
State: CO

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore in arm; Small bump in injection spot; Itchy; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 06Apr2021 at 15:45 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies to food, medications, or other products. Concomitant medications included vitamin d nos (VITAMIN D) and birth control; both for unknown indications from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient experienced sore in arm, small bump in injection spot and itchy. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sore in arm, small bump in injection spot and itchy was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: Vitamin d

Current Illness:

ID: 1525035
Sex: M
Age:
State: NC

Vax Date: 04/06/2021
Onset Date: 04/01/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Odd bruising on the upper part of back. Both sides of spine.; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP7534) via an unspecified route of administration in the left arm on 06Apr2021 at 16:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. The patient did not have any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: EL9266) via an unspecified route of administration in the left arm on 09Mar2021 at 17:00 (at the age of 40-years-old) as a single dose for Covid-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced odd bruising on the upper part of back and on both sides of spine. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event odd bruising on the upper part of back and on both sides of spine was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1525036
Sex: M
Age:
State: OH

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash on chest and right side of neck; Headache; Fever; Chills.; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 07Apr2021 at 16:30 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history included cancer, radiation thyroiditis, crohn's disease and arthritis. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), hydrocodone bitartrate, paracetamol (NORCO), lisinopril dihydrate (LISINOPRIL), levothyroxine (MANUFACTURER UNKNOWN) and meloxicam (MELOXIC); all from unknown date for unknown indication. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 24Mar2021 at 17:00 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 20:00, the patient experienced rash on chest and right side of neck, headache, fever and chills. it was reported that he was prior cancer patient, right side squamous cell carcinoma resection lymph nodes removed on this side as well as radiation effects. All treatment from 2017-2018, nothing recently. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events rash, headache, fever and chills was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: ADDERALL; NORCO; LISINOPRIL; LEVOTHYROXINE; MELOXIC

Current Illness:

ID: 1525037
Sex: F
Age:
State: OR

Vax Date: 03/04/2021
Onset Date: 03/04/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: slight sore arm; Lethargic; Fever; very low energy; Cough; Flu; feeling of inflammation; Lot of stuffiness; Post nasal drip; This is a spontaneous report from a non-contactable consumer, the patient. A 53-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6202) via an unspecified route of administration in the left arm on 04Mar2021 at 07:45 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included hyperthyroid. The patient had a history of allergy to sulfa, mold and hornets. the patient received other medications included montelukast (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN) and estradiol (ESTROGEN) and vitamins (MANUFACTURE UNKNOWN) for unknown indication within 2 weeks of vaccination. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: el9262) via an unspecified route of administration in the left arm on 10Feb2021 at 15:45 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04Mar2021, the patient had experienced slight sore arm, lethargic, fever, loss of energy, cough, flu which was lasted for 32 hours and felt better however, she was feeling of inflammation, lot of stuffiness and post nasal drip. The patient reported that she was not sure if her allergies or shot or shot triggered the excess inflammation in body and she was still fighting it off along with allergies kicking in. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event flu was resolving while the outcome of the events slight sore arm, lethargic, fever, loss of energy, cough, feeling of inflammation, lot of stuffiness and post nasal drip was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: MONTELUKAST; GABAPENTIN; ESTROGEN

Current Illness:

ID: 1525038
Sex: F
Age:
State: MI

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: bfever x 1 day after her second covid vaccine injection; This is a spontaneous report from a contactable consumer(patient). A 54-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of injection on 08Apr2021, at 54-year-old, as single dose (Batch/Lot number was not reported) for covid-19 immunisation. The patient medical history included ongoing malignant neoplasm of breast from an unspecified date. Concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date, as single dose (Batch/Lot number was not reported) for covid-19 immunisation. The patient stated that she had a fever x 1 day after her second covid vaccine injection on 09Apr2021. The outcome of events was unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness: Malignant breast neoplasm

ID: 1525039
Sex: F
Age:
State: FL

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tachycardia; Palpitations; Breathlessness; This is a spontaneous report from a contactable other health care professional. A 35-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 08Apr2021 13:30 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE) taken for an unspecified indication, start and stop date were not reported. The patient experienced tachycardia, palpitations, breathlessness on 09Apr2021 with outcome of not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: LO LOESTRIN FE

Current Illness:

ID: 1525040
Sex: F
Age:
State:

Vax Date: 04/19/2021
Onset Date: 04/25/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: triggered serious thyroiditis symptoms; painful thyroid, triggered serious thyroiditis symptoms; This is a spontaneous report from a non-contactable consumer or other non HCP (patient). A 44-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown), dose 1 via an unspecified route of administration on 19Apr2021 as dose 1, single for COVID-19 immunization. Medical history included thyroiditis. Concomitant medication was not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, patient has not been tested for COVID-19. On 25Apr2021, the patient experienced painful thyroid and triggered serious thyroiditis symptoms. The outcome of the events was not recovered. Information of the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1525041
Sex: U
Age:
State: VA

Vax Date:
Onset Date:
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: the patient's skin totally exfoliated.; patient has been diagnosed with PRP (Pityriasis rubra pilaris).; This is a spontaneous report from a contactable physician. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced as, the patient's skin totally exfoliated, patient had been diagnosed with prp (pityriasis rubra pilaris) on an unspecified date. Reported as, HCP stated they would love if there was anymore information about any other kind of rash besides urticaria or anaphylaxis. This was not an histamine related reaction with her patient and she had since been diagnosed, which caller did not believe that it is this, patient has been diagnosed with PRP (Pityriasis rubra pilaris). It's so rare and this was from what the biopsy showed by someone else who gave the diagnosis. It was pretty bad. Patient's skin totally exfoliated. No further details provided. It was not a product complaint and no medical information request reported. Outcome of the event were unknown. Information on the Lot/batch number has been requested. Follow-up (22Jul2021): New information reported from a contactable Physician in response to Physician outbound call which included: events were coded and the case was considered valid from invalid. Information on the Lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1525042
Sex: F
Age:
State: AZ

Vax Date: 05/01/2021
Onset Date: 05/04/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Foggy eyesight; Sore throat; Swollen throat; Dry Mouth; Swollen face; Fever; Extreme joint pain; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right upper arm on 01May2021 at 09:15 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was reported as none. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04May2021 at 14:00, the patient experienced foggy eyesight, fever, dry mouth, extreme joint pain, sore throat, swollen face and throat. The clinical outcomes of the events foggy eyesight, fever, dry mouth, extreme joint pain, swollen face and throat, and sore throat were recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1525043
Sex: F
Age:
State: NY

Vax Date: 05/03/2021
Onset Date: 05/05/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pains in armpit; Swollen lymph node in armpit; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0172) via an unspecified route of administration in the arm left on 03May2021 at 09:00(at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included fluticasone propionate, salmeterol xinafoate (ADVAIR) and loratadine (CLARITIN) from unknown dates and for unknown indications. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8729) via an unspecified route of administration in the arm left on 12Apr2021 at 09:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021 at 08:00, the patient experienced pains in armpit and swollen lymph node in armpit. The clinical outcome of the event pains in armpit and swollen lymph node in armpit were unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ADVAIR; Claritin

Current Illness:

ID: 1525044
Sex: F
Age:
State:

Vax Date: 04/23/2021
Onset Date: 05/03/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Started another period, and bled for a full 5 days/ breakthrough bleeding; Fever; Chills; Shivering; Headache; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 23Apr2021 at 14:30 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced fever, chills, shivering, headache and fatigue for about two days. On 03May2021 the patient experienced irregular menstruation. She was on last 2 days of period while vaccination and after 10 days of the vaccine, started another period and bled for a full 5 days. The blood was somewhat thinner than it is in a usual period. She had rarely had such breakthrough bleeding in between her cycle and felt was likely a side effect of the vaccine. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event fever, chills, shivering, headache and fatigue was recovered on an unknown date in 2021; while that of irregular menstruation was unknown at the time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1525045
Sex: F
Age:
State: NH

Vax Date: 04/27/2021
Onset Date: 05/06/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Menstrual cycle was early by 3 weeks; This is a spontaneous report from a non- contactable consumer, the patient. A 16-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine, lot number: unknown) via an unspecified route of administration in the left arm on 27April2021 at 15:00 (16-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no known allergies. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 06May2021, nine days after vaccination, the patient experienced a menstrual cycle, which was early by 3 weeks. No therapeutic measures were taken for the adverse event. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1525046
Sex: F
Age:
State: FL

Vax Date: 04/30/2021
Onset Date: 04/30/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Extreme nauseous feeling; Extreme tiredness; Extreme tiredness/fatigue/feverish feeling with no fever; Extreme tiredness/fatigue/feverish feeling with no fever; headaches; foggy feeling; Dizziness; High glucose; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Apr2021 at 09:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included type 1 diabetes, diabetic retinopathy and gastroparesis. Concomitant medications included insulin lispro (HUMALOG), ascorbic acid (VITAMIN C), calcium citrate; cholecalciferol (CALCIUM CITRATE + D) and Xa (MANUFACTURER UNKNOWN); all for unknown indications on unknown dates. The patient previously received codeine (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 15:30, 6 hours after shot, the patient experienced dizziness. Everyday since first shot, the patient experienced high glucose everyday, extreme nauseous feeling, extreme tiredness/fatigue/ feverish feeling with no fever, some dizziness throughout the day, headaches and foggy feeling. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events of dizziness, high glucose everyday, extreme nauseous feeling, extreme tiredness/fatigue/feverish feeling with no fever, headaches and foggy feeling were not recovered at the time of this report. No follow-up attempts are needed; information about lot number cannot be obtained.

Other Meds: HUMALOG; Vitamin c; CALCIUM CITRATE + D

Current Illness:

ID: 1525047
Sex: F
Age:
State: OH

Vax Date: 05/04/2021
Onset Date: 05/05/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: severe surface full body pain to the touch; It seemed as if my musclesweren't sore but everything on top of them was; skin was painful; so much severe pain unable to do anything for the remainder of the day; severe headache/head pain; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04May2021 at 14:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to azithromycin (MANUFACTURER UNKNOWN). The patient did not receive any other medications within two weeks of the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 14:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05May2021 at 03:30, the patient experienced severe surface full body pain to the touch, it was seemed as muscles were not sore but everything on top of them was sore. The skin was painful to touch and the patient was in so much severe pain and unable to do anything for the remainder of the day. This also came along with a severe headache/head pain that has lingered since. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events severe surface full-body pain to the touch, muscles were not sore but everything on top of them was sore, skin painful, so much severe pain and unable to do anything for the remainder of the day, and severe headache/head pain were recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1525048
Sex: F
Age:
State: OR

Vax Date: 04/17/2021
Onset Date: 04/18/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Lump in armpit, it was hard and around the size of a large lima bean; Soreness in left armpit; Discomfort; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old, non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0161) via an unspecified route of administration on 17Apr2021 at 10:15 (at the age of 31-years-old) as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 18Apr2021 at 00:00 hours, the day after the first vaccination, the patient experienced soreness in her left armpit. On 23Apr2021, six days out of the first dose, the patient had a lump in her armpit. It was hard and around the size of a large lima bean. After reading reports and side effect information of swollen lymph nodes she waited several days. The lump was gone by day 9 and the discomfort faded by 12 days after the first vaccine shot. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of the events of soreness in left armpit was recovered on an unknown date in 2021, the event of lump in armpit was recovered on 26Apr2021 for a duration of 3 days and for the event of discomfort was recovered on 29Apr2021 for a duration of 12 days. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1525049
Sex: M
Age:
State: CO

Vax Date: 04/29/2021
Onset Date: 04/29/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen eyes; Swollen mouth; Joint pains; Fatigue; Nausea; Vomiting; Diarrhea; This is a spontaneous report from a contactable other healthcare professional. A 56-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route on 29Apr2021 (at an age of 56-years-old) as single dose for COVID-19 immunisation. Medical history and concomitant medications of patient was not reported. It was unknown if the patient received medications within 2 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Post the vaccination, the patient was not tested for COVID-19. On 29Apr2021, 5 hours after vaccine, the patient had swollen eyes and mouth, joint pains, fatigue, nausea, vomiting and diarrhea. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events. The clinical outcome of the events of swollen eyes, mouth swelling, joint pains, fatigue, nausea, vomiting and diarrhea were not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1525050
Sex: F
Age:
State: OH

Vax Date: 05/05/2021
Onset Date: 05/06/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: red lump under injection site, painful to touch.; Injection site bruising; Red lump under injection site; red lump under injection site, painful to touch.; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 05May2021 at 11:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications include multivitamins- one a day women's (MANUFACTURER UNKNOWN) since an unknown date for unknown indication. It was not reported whether the patient had allergies to medications, food, or other products. The patient received medications within two weeks prior the vaccination. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Previously, the patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 15Apr2021 at 9:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. On 06May2021 at 11:00, the patient experienced injection site bruising, red lump under injection site, painful to touch. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events injection site bruising, red lump under injection site, painful to touch were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1525051
Sex: M
Age:
State: MI

Vax Date: 04/26/2021
Onset Date: 04/26/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Muscle spasms in right arm, not the arm where injection was made.; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Apr2021 at 10:45 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as no. The patient did not have allergy to any medications, food, or other products. The patients past drug was reported as no. Concomitant medications taken within two weeks prior to the vaccination included ibuprofen (MANUFACTURER UNKNOWN) from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021 at 16:30, the patient experienced muscle spasms in right arm, not the arm where injection was made. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event muscle spasms in right arm, not the arm where injection was made was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: IBUPROFEN

Current Illness:

ID: 1525052
Sex: F
Age:
State: PA

Vax Date: 04/11/2021
Onset Date: 04/30/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Severe dizziness; Visual disturbances; Nauseous; Sweaty; first turned on my side, since I didn't want to rush to get up. When doing so with eyes opened, they flickered without me doing so.; Able to rise but had help walking and sitting; Vertigo; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198), via an unspecified route of administration in the left arm on 11Apr2021 at 10:00 (at the age of 64-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as various. The patient had known allergies. Concomitant medications included sotalol (MANUFACTURER UNKNOWN), warfarin (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPIRIN) and magnesium (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534), via an unspecified route of administration in the left arm on 19Mar2021 at 11:15 (at the age of 64-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 00:30, the patient awaked from sleep with severe dizziness, visual disturbances, also nauseous and sweaty, the patient first turned-on side, since didn't want to rush to get up, when doing so with eyes opened, they flickered without doing so. Finally able to rise but had help walking and sitting, the patient still experiencing dizziness/ vertigo since that evening with periodic episodes. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of severe dizziness, visual disturbances, nauseous, sweaty, eyes flickered, unable to walk and sit without help, vertigo and included treatment with meclizine (MANUFACTURER UNKNOWN) from an unknown date. The clinical outcome of the events severe dizziness, visual disturbances, nauseous, sweaty, eyes flickered without doing so, able to rise but had help walking and sitting and vertigo were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SOTALOL; WARFARIN; Aspirin; MAGNESIUM

Current Illness:

ID: 1525053
Sex: M
Age:
State: OH

Vax Date: 04/25/2021
Onset Date: 04/27/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fatigue and lethargy; lethargy; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 25Apr2021 at 16:00(at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history were reported as none. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 04Apr2021 at 13:15(at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 27Apr2021 at 21:00, the patient experienced fatigue and lethargy. The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event fatigue and lethargy was recovered on unknown date in 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1525054
Sex: F
Age:
State: CA

Vax Date: 04/01/2021
Onset Date: 04/02/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: uncontrolled crying; I was fatigued; had the chills. (both doses); I have a persistent headache on the right side.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8734) via an unspecified route of administration in the right arm on an unknown date in Apr2021 at 09:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the right arm on an unknown date in Apr2021 at 09:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes. Concomitant medications included metformin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and pravastatin sodium (PRAVACHOL) for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 the patient experienced Emotional reaction - uncontrolled crying (both doses) she was fatigued and had the chills (both doses) she had a persistent headache on the right side. No therapeutic measures were taken as a result of the events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events uncontrolled crying, fatigued, chills and persistent headache were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: METFORMIN; PRAVACHOL

Current Illness:

ID: 1525055
Sex: F
Age:
State: WI

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: muscle ache at site of injection; very tired; This is a spontaneous report from a contactable other healthcare professional, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 06Apr2021 at 12:00 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history included seafood allergy. The patient received unspecified medications within two weeks of vaccination. The patient previously took augmentin (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 17:00, the patient experienced muscle ache at site of injection which lasted for 2 days and very tired. The patient did not receive any treatment for the reported events. The events did not result in any of these doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event of injection site muscle pain was recovered on 08Apr2021 while the clinical outcome of tiredness was recovered on an unknown date in Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1525056
Sex: F
Age:
State: CO

Vax Date: 04/30/2021
Onset Date: 05/01/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Extreme vertigo; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 30Apr2021 at 14:45 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. The patient did not had any relevant medical history and known allergies. Concomitant medications included ibuprofen (ADVIL) from an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 21:00, the patient experienced extreme vertigo. Therapeutic measures were taken as a result of the event of extreme vertigo and included treatment with upper cervical chiropractor. The adverse event resulted in doctor or other healthcare professional office or clinic visit. The clinical outcome of the event of vertigo was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Advil

Current Illness:

ID: 1525057
Sex: F
Age:
State:

Vax Date: 04/01/2021
Onset Date:
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore shoulder; Fatigue; Feverish lasting about five hours; This is a spontaneous report from a non-contactable consumer, the patient. A 58-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8733) via an unspecified route of administration on an unknown date in Apr2021 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced sore shoulder, fatigue and feverish lasting about five hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sore shoulder, fatigue and feverish lasting about five hours was recovered on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1525058
Sex: M
Age:
State: MD

Vax Date: 03/19/2021
Onset Date:
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vitiligo on both of hands and face; This is a spontaneous report from a contactable physician. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via intramuscular route of administration in the left arm on 19Mar2021 (at the age of 50-years-old) as a single dose for COVID-19 immunisation and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via intramuscular route of administration in the left arm on 13Apr2021 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any concomitant medication within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient had vitiligo on both of his hands and his face. It was reported that he did not have this problem prior to vaccination. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event and included an unspecified treatment. The clinical outcome of the event vitiligo on both of hands and face was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1525059
Sex: F
Age:
State: MI

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Metallic taste directly after, lasted all day; This is a spontaneous report from a contactable consumer, the patient. A 36-years-old non-pregnant female patient received an unspecified dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the right arm on 14Apr2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had known allergies to latex. Concomitant medications included intrauterine contraceptive device (IUD) used for unknown indication, from unspecified dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, the patient experienced metallic taste directly after which lasted all day. No therapeutic measures were taken as a result of reported events. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/ department or urgent care. The clinical outcome of the event metallic taste recovered on an unknown date in 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: IUD

Current Illness:

ID: 1525060
Sex: F
Age:
State:

Vax Date: 03/31/2021
Onset Date: 04/01/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash covering both arms; This is a spontaneous report from a non-contactable nurse. A 24-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration on 31Mar2021 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On 01Apr2021, next day after the first dose, the patient experienced rash covering both the arms. Therapeutic measures were taken as a result of the event and included treatment with hydrocortisone cream and ice packs. The clinical outcome of the event rash covering both arms was resolved on 02Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1525061
Sex: F
Age:
State: NE

Vax Date: 05/02/2021
Onset Date: 05/05/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: hives all over abdomen, back, bottom,legs, arms, neck; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02May2021 at 12:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included endometriosis, migraine and COVID-19. The patient was allergic to penicillin and latex. Concomitant medications included norethisterone (NORETHINDRONE), spironolactone (MANUFACTURER UNKNOWN) and diphenhydramine hydrochloride (BENADRYL) all from unknown date for unspecified indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Apr2021 at 12:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19 on an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021 at 14:00, the patient experienced hives all over abdomen, back, bottom, legs, arms and neck. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event hives all over abdomen, back, bottom, legs, arms, and neck was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: Norethindrone; SPIRONOLACTONE; BENADRYL

Current Illness: Latex allergy; Penicillin allergy

ID: 1525062
Sex: F
Age:
State: CA

Vax Date: 03/27/2021
Onset Date: 04/01/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: hands had mild swelling; intermittent tingling in the thumb and forefinger; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: fr8730) via an unspecified route of administration in the left arm on 27Mar2021 at 16:15 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as allergies to penicillin allergy, possible shellfish allergy. No concomitant medication was reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6199) via an unspecified route of administration in the left arm on 06Mar2021 at 16:15 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced approximately 2 weeks after the 2nd shot hands had mild swelling and intermittent tingling in the thumb and forefinger that continues to be an ongoing problem, the patient had not seen a doctor yet but planning to make an appointment in next few days. No therapeutic measures were taken as a result of the adverse events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event hands had mild swelling, intermittent tingling in the thumb, intermittent tingling in the forefinger was not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1525063
Sex: M
Age:
State: IL

Vax Date: 05/04/2021
Onset Date: 05/04/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I had a low grade feverstarting around 2-3 hours after mysecond vaccine, which quickly rose toaround 103 about 14 hours after myvaccination; Full body chills; Muscle weakness; Headache; This is a spontaneous report from a contactable consumer, the patient. A 37-years-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 04May2021 at 10:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The had no known allergies. Concomitant medications included colecalciferol (VITAMIN D3) (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN) all for unknown indication, from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 13Apr2021 at 16:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04May2021 at 23:30 the patient experienced high fever (103 degree Fahrenheit), full body chills, muscle weakness, sore arm, headache. He had a low-grade fever starting around 2-3 hours after his second vaccine, which quickly rose to around 103 about 14 hours after his vaccination, where it stayed for around 3 hours. He took 500 milligrams of acetaminophen when his fever rose but it did not reduce it below 103.The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of high fever, full body chills, muscle weakness, sore arm, headache and included treatment with acetaminophen 500 milligrams from unspecified start date to unspecified stop date. On 04May2021, patient underwent lab tests and procedures, which included, body temperature and the result was 103 Degrees Fahrenheit. The clinical outcome of the events fever, full body chills, muscle weakness, sore arm and headache was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN D3; FISH OIL; IBUPROFEN

Current Illness:

ID: 1525064
Sex: F
Age:
State: FL

Vax Date: 05/05/2021
Onset Date: 05/05/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: About t25 minutes after receiving second shot, my right hip replacement area became very painful. It was difficult to walk for a few hours. The next day I could walk but entire hip area was painful.; About t25 minutes after receiving second shot, my right hip replacement area became very painful. It was difficult to walk for a few hours. The next day I could walk but entire hip area was painful.; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 05May2021 at 12:15 (at the age of 69-year-old), as a single dose for COVID-19 immunisation. Medical history included blood pressure high. The patient did not have any known allergies. Concomitant medications were unspecified. The patient also received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on an unknown date in 2021 (at the age of 69-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05May2021 at 12:45, the patient experienced about 25 minutes after receiving second shot, her right hip replacement area became very painful. It was difficult to walk for a few hours. The next day the patient could walk but entire hip area was painful. The adverse events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the events pain in hip (right hip replacement area) and walking difficulty was recovering. No follow-up attempts are possible; Information on lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1525065
Sex: F
Age:
State: CA

Vax Date: 02/06/2021
Onset Date: 03/12/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Abnormal menstrual cycle.; Ultrasound finds large cysts; Late one month by 5 days, then Arrived two weeks late- otherwise always 28 days.; This is a spontaneous report from a contactable physician. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 06Feb2021 at 11:00 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food or other products. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 09 Jan2021 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Mar2021, the patient experienced abnormal menstrual cycle, late one month by 5 days, then arrived two weeks late otherwise always 28 days and ultrasound finds large cysts. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. On 10Apr2021, the patient underwent nasal swab color test and the result was negative. The clinical outcome of the events abnormal menstrual cycle, late one month by 5 days, then arrived two weeks late otherwise always 28 days and ultrasound finds large cysts were recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1525066
Sex: F
Age:
State:

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: dizziness; lightheartedness; This is a spontaneous report from a non-contactable pharmacist. A 62-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8733), via an intramuscular route of administration in the right arm on 19Apr2021 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included elevated BP(blood pressure). Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8727) via an intramuscular route of administration in the left arm on 29Mar2021 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021, the patient experienced dizziness and lightheartedness. It was reported that the patient felt elevated BP prior to vaccination and patient left RUHS 30 minutes after vaccine administration. The patient underwent lab tests of vital signs pre-vaccine on 19Apr2021 which included BP of 166/77, HR(heart rate) of 68, O2(oxygen saturation) of 96% and she was given 8oz of water. The patient underwent vitals signs again 10 minutes later which was found to be a BP of 138/66, HR of 66, O2 of 96% and BG(blood glucose) of 132. The patient did not receive any treatment for the reported events. The clinical outcomes of the events dizziness and lightheartedness was recovered on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1525067
Sex: F
Age:
State: CA

Vax Date: 03/01/2021
Onset Date: 04/01/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Feeling cramps and bloating; Feeling cramps and bloating; Extreme cramping and bloating and some spotting. I dont normally bleed during my period because I have the Mirena IUD; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 01Mar2021 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as no. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on an unknown date in 2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 08:00, the patient experienced period cycle symptoms which lasted as usual for 3-7 days. The patient started feeling period symptoms again on 08Apr2021 and had been feeling that since long. The patient's period cycle was usually in the beginning of the month. On 26Apr2021, the patient started spotting again, feeling cramps and bloating. The patient had period symptoms for a full month. Extreme cramping and bloating and some spotting. The patient had Mirena IUD and hence do not normally bleed during period. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events spotting menstrual, cramps and bloating was not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1525068
Sex: F
Age:
State: MN

Vax Date: 04/10/2021
Onset Date: 04/12/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hives on torso, arms, and legs; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 10Apr2021 at 09:30(at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included hashimotos disease and high cholesterol. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and rosuvastatin (MANUFACTURER UNKNOWN) from an unknown date for unspecified indication. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the right arm on 20Mar2021 at 09:45 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 09:30 the patient experienced hives on torso, arms, and legs. On 13Apr2021, the patient underwent (COVID 19 virus test) and the result was negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of hives on torso, arms, and legs and included treatment with Benadryl (MANUFACTURER UNKNOWN) on her own on an unknown date. The clinical outcome of the event hives on torso, arms, and legs was resolved on an unknown date. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE; ROSUVASTATIN

Current Illness:

ID: 1525069
Sex: M
Age:
State: CA

Vax Date: 04/08/2021
Onset Date: 04/30/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: a rash with small blisterson back, on the left shoulder bladeclose to the spine. It's itchy and has aslight burning sensation; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP0161) via an unspecified route of administration in the left arm on 08Apr2021 at 14:45 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Patient had no relevant medical history. The patient did not received any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 18Mar2021 at 13:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021, the patient experienced shingles. Its reported that about a week ago (late April) patient developed a rash with small blisters on back, on the left shoulder blade close to the spine. It's itchy and had a slight burning sensation. From an online search patient believe it's shingles. (had chicken pox as a child). He was 38 and never had shingles before. Now it seems that it started to dry out. The patient did not receive any treatment for the reported event. The patient events did not result in any of these doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event of shingles was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1525070
Sex: M
Age:
State: FL

Vax Date: 05/03/2021
Onset Date: 05/04/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Nausea; pale diarrhea; gas; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03May2021 at 16:45 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included type 1 diabetes mellitus, hashimoto's thyroiditis from an unspecified date. The patient had no known allergies. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), insulin degludec (TRESIBA), insulin lispro (HUMALOG) from an unknown date for an unspecified indication. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04May2021 at 06:00 the patient experienced nausea, gas, and pale diarrhea still 4 days after 2nd dose. The patient did not receive treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events nausea, diarrhea, gas was not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LEVOTHYROXINE; TRESIBA; HUMALOG

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm